Skip to main content

Radiopharmaceutical quality assurance

Edited by:
Diane S. Abou, PhD., Washington University in St. Louis, Mallinckrodt Institute of Radiology, United States
Erik de Blois, PhD., Erasmus University Rotterdam, The Netherlands

Submission Status: Open   |   Submission Deadline: 10 November 2025


This collection aims to showcase pioneering research focused on quality assurance in the production and use of radiopharmaceuticals. We invite contributions that explore innovative methodologies, validation processes, and analytical techniques essential for ensuring drug safety and regulatory compliance. By fostering dialogue in this critical area, we hope to advance the field of nuclear medicine and improve patient outcomes through enhanced quality standards.

About the collection

Back to top

The field of radiopharmaceuticals is essential for the advancement of nuclear medicine, enabling accurate diagnosis and targeted therapy. However, the inherent complexity of these compounds necessitates rigorous quality assurance protocols to ensure their safety, efficacy, and reliability. This Collection invites research that delves into the various aspects of quality assurance in radiopharmaceutical production, encompassing the validation processes, analytical methods, and compliance with regulatory standards that are crucial for maintaining the integrity of these vital medical agents.

The significance of robust quality assurance in radiopharmaceuticals is underscored by the critical role these substances play in patient care. Recent advancements in analytical techniques and quality control measures have improved the reliability of radiopharmaceuticals, minimizing risks associated with drug safety. Additionally, the emergence of innovative production methods and technology-driven solutions has enhanced the capacity to meet stringent regulatory requirements, ultimately leading to safer and more effective therapeutic options for patients.

This collection focuses on analytical method development and validations across the radiopharmaceutical spectrum including diagnostic and therapeutic isotopes, cGMP practice of radiopharmaceutical, fitting with world-wide regulatory expectations. Moreover, ongoing research could pave the way for developing standardized protocols that can be universally applied, thereby improving consistency across the industry and fostering greater trust in radiopharmaceutical therapies.

Topics of interest include but are not limited to:

  • Innovations in quality assurance methodologies
  • Analytical methods in radiopharmaceutical quality control
  • Validation processes for radiopharmaceuticals
  • Enhancing drug safety in nuclear medicine

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system. During the submission process, under the section additional information, you will be asked whether you are submitting to a Collection, please select "Radiopharmaceutical quality assurance" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

There are currently no articles in this collection.